0001104659-14-062739.txt : 20140822 0001104659-14-062739.hdr.sgml : 20140822 20140822171630 ACCESSION NUMBER: 0001104659-14-062739 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140822 DATE AS OF CHANGE: 20140822 EFFECTIVENESS DATE: 20140822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ContraVir Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001583771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462783806 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-223509 FILM NUMBER: 141061104 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 2012 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-297-0020 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 2012 CITY: NEW YORK STATE: NY ZIP: 10170 D 1 primary_doc.xml X0707 D LIVE 0001583771 ContraVir Pharmaceuticals, Inc. 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 212-297-6149 DELAWARE None None Corporation true 2013 James Sapirstein 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Executive Officer Director Gary Jacob 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Director Bill Hornung 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Executive Officer John Brancaccio 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Director Christopher McGuigan 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Director Timothy Block 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Director Biotechnology No Revenues 06b false 2014-08-20 false true false 0 4742648 4742648 0 false 19 0 0 0 true ContraVir Pharmaceuticals, Inc. /s/ James Sapirstein James Sapirstein Chief Executive Officer 2014-08-22